JD Health International, Inc. (HK:6618) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
JD Health International Inc. announced the grant of 2.6 million share awards to employees under its Post-IPO Share Award Scheme, with no performance targets attached and a vesting period ranging from six months to four years. The shares were granted on October 1, 2024, with a market price of HK$35.00 per share, and include a clawback mechanism to protect the company’s interests in cases of misconduct.
For further insights into HK:6618 stock, check out TipRanks’ Stock Analysis page.